Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus

Summary

This study will assess the safety and efficacy of secukinumab on the preservation of pancreatic beta cells in patients with newly-diagnosed type 1 diabetes mellitus.

Timeline

Start

2014-02

Primary completion

2014-09

Completion

2014-09

Outcome

Outcome not reported

Stopped (Business): “This study was terminated prematurely by the Sponsor for business reasons only.”

Drugs

Indications